Bioerodible magnesium alloy microstructures for endoprostheses
US-9522220-B2 · Dec 20, 2016 · US
US11732334B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11732334-B2 |
| Application number | US-201816500928-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 12, 2018 |
| Priority date | Apr 12, 2017 |
| Publication date | Aug 22, 2023 |
| Grant date | Aug 22, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to biodegradable, metal alloys, methods for their preparation and applications for their use. The alloys include magnesium and other components, such as, yttrium, calcium, zirconium, and zinc. These elements are alloyed together in specific combinations and amounts in order to achieve an alloy having desired properties and characteristics. In certain embodiments, strontium or cerium may be included as an additive. The resulting alloys are particularly suitable for forming various medical devices for implantation into the body of a patient.
Opening claim text (preview).
The invention claimed is: 1. A biodegradable medical implant device, comprising: a biodegradable, extruded metal alloy, consisting of: about 4.0 weight percent of yttrium; from about 0.5-0.6 weight percent of calcium; from about 0.6-1.0 weight percent of zirconium; about 2.0 weight percent of zinc; and a balance of magnesium including impurities, based on the total weight of the composition, wherein the biodegradable, extruded metal alloy is a solid solution, and intermetallic phases are precluded other than a long period stacking order phase Mg 12 YZn, and wherein the metal alloy has ultimate tensile strength from about 375 to about 410 MPa and yield tensile strength from about 335 to about 345 MPa, and exhibits proliferation of cells and corresponding osteogenic differentiation. 2. The medical implant device of claim 1 , wherein the calcium constitutes about 0.6 weight percent and the zirconium constitutes about 1.0 weight percent. 3. The medical implant device of claim 1 , wherein the zirconium constitutes about 0.6 weight percent. 4. The medical implant device of claim 1 , wherein the impurities comprise one or more of iron, nickel, and copper. 5. The medical implant device of claim 1 , wherein the impurities constitute 20 ppm or less. 6. The medical implant device of claim 1 , wherein the metal alloy has elongation about 15%.
with a rare earth metal as the next major constituent · CPC title
Materials at least partially resorbable by the body · CPC title
Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06 · CPC title
with zinc or cadmium as the next major constituent · CPC title
Materials at least partially resorbable by the body · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.